Tanner D J, Nazarian M Q
Am J Med. 1984 Oct 19;77(4C):104-11.
Multi-region time and motion studies were conducted in hospitals of various sizes to determine the cost of personnel and supplies associated with the preparation, dispensing, and administration of reconstituted parenteral antibiotics. The administration systems studied included the piggyback intravenous admixture (including several batch methodologies), the volume control intravenous set, and intramuscular techniques. Supply costs were calculated for each system. Projections of potential cost savings resulting from decreased administrations of parenteral cephalosporins were calculated for surgical prophylaxis, 10-day treatment course, and average per bed hospital use. The projected cost savings for the first 24 hours of surgical prophylaxis, or a 10-day treatment course changing from every eight- to six-hour dosing to a single daily dose ranged from $5.60 to $24.25 and $28 to $145, respectively. The average hospital's projected cost savings potential per hospital bed resulting from decreased administration of parenteral cephalosporins depended on the administration system or systems used and ranged from $35 (25 percent reduction in doses) to $364 (75 percent reduction in doses). An algorithm is presented for individual hospitals to use in calculating cost containment estimates. Clinicians and health care managers should seriously consider the cost containment advantages provided by the substitution of newer antibiotics which permit reduced administration frequency.
在不同规模的医院开展了多区域时间与动作研究,以确定与复溶肠胃外抗生素的配制、分发及给药相关的人员和物资成本。所研究的给药系统包括静脉滴注(包括几种批量方法)、容量控制静脉输液器及肌肉注射技术。计算了每个系统的供应成本。针对手术预防、10天疗程以及医院每张床位的平均使用情况,计算了因减少肠胃外头孢菌素给药量而可能节省的成本。手术预防的头24小时或从每8小时给药一次改为每6小时给药一次再改为每日单次给药的10天疗程,预计节省的成本分别为5.60美元至24.25美元以及28美元至145美元。每家医院因减少肠胃外头孢菌素给药量而预计每张床位节省的成本潜力取决于所使用的给药系统,范围从35美元(剂量减少25%)至364美元(剂量减少75%)。本文给出了一种算法,供各医院用于计算成本控制估算值。临床医生和医疗保健管理人员应认真考虑更换为允许减少给药频率的新型抗生素所带来的成本控制优势。